| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.53B | +40.6% |
| Cost of Revenue | $1.22B | +42.5% |
| Gross Profit | $304.1M | +33.2% |
| R&D Expense | $26.5M | +35.5% |
| SG&A Expense | $180.6M | +44.9% |
| Operating Income | $73.1M | +6.7% |
| Pre-tax Income | $11.2M | -73.1% |
| Income Tax | $1.5M | -86.4% |
| Net Income | $9.7M | -68.3% |
| EPS (Basic) | $0.17 | -77.6% |
| EPS (Diluted) | $0.17 | -77.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.5M | +51.2% |
| Accounts Receivable | $310.8M | +78.6% |
| Inventory | $346.4M | +49.7% |
| Current Assets | $877.7M | +69.4% |
| Total Assets | $2.01B | +84.6% |
| Current Liabilities | $461.3M | +72.6% |
| Long-term Debt | $595.0M | +48.8% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.0M | -87.0% |
| Capital Expenditures | $14.2M | +4.5% |
| Investing Cash Flow | $5.8M | +163.9% |
| Financing Cash Flow | $16.3M | +146.1% |
| Free Cash Flow | -$5.2M | -109.5% |
| $1.19B |
| +65.1% |
| Stockholders' Equity | $814.9M | +123.2% |